Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Vaccine. 2010 Feb 25;28(9):2076-9. doi: 10.1016/j.vaccine.2009.12.041. Epub 2009 Dec 29.

A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects.

Author information

  • 1Baylor College of Medicine, One Baylor Plaza, MS: BCM 280, Houston, TX 77030, United States. tcate@bcm.edu

Abstract

Antibody to the neuraminidase (NA) antigen of influenza viruses has been shown to correlate with immunity to influenza in humans and animal models. In a previous report, we showed that an inactivated influenza vaccine containing 60microg of the hemagglutinin (HA) of each strain induced significantly more serum anti-HA antibody among elderly persons than did the standard vaccine containing 15microg of the HA of each component. We developed a lectin-based assay for anti-NA antibody and used it to measure anti-NA antibody responses among subjects who had participated in that study. The high dosage vaccine contained eight times as much NA activity as the standard vaccine and induced a significantly higher frequency of antibody responses and higher mean postvaccination anti-NA titers to the N1 and N2 of the A/H1N1 and A/H3N2 viruses in the vaccines than did the standard vaccine. Ensuring an increased antibody response to the NA antigen in inactivated influenza virus vaccines should increase the protection against influenza. An increased quantity of the NA antigen in the vaccine will ensure an increased response.

Copyright 2009 Elsevier Ltd. All rights reserved.

PMID:
20044052
[PubMed - indexed for MEDLINE]
PMCID:
PMC2853016
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk